Pulmonary Hypertension and Right Ventricular Failure in Emergency Medicine

被引:52
|
作者
Wilcox, Susan R. [1 ]
Kabrhel, Christopher [1 ]
Channick, Richard N. [2 ]
机构
[1] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Med, Div Pulm & Crit Care, Boston, MA 02114 USA
关键词
CHEST COMPUTED-TOMOGRAPHY; ARTERIAL-HYPERTENSION; HEART-FAILURE; MANAGEMENT STRATEGIES; NATRIURETIC PEPTIDE; NITRIC-OXIDE; DIAGNOSIS; NOREPINEPHRINE; DYSFUNCTION; PATIENT;
D O I
10.1016/j.annemergmed.2015.07.525
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Pulmonary hypertension is a hemodynamic condition, defined as a mean pulmonary artery pressure by right-sided heart catheterization of at least 25 mm Hg at rest. It is classified into 5 general groups based on the underlying cause, with left ventricular failure and chronic obstructive pulmonary disease being 2 of the most common causes in the United States. Although the specifics of the pathophysiology will vary with the cause, appreciating the risks of pulmonary hypertension and right ventricular failure is critical to appropriately evaluating and resuscitating pulmonary hypertension patients in the emergency department (ED). Patients may present to the ED with complaints related to pulmonary hypertension or unrelated ones, but this condition will affect all aspects of care. Exertional dyspnea is the most common symptom attributable to pulmonary hypertension, but the latter should be considered in any ED patient with unexplained dyspnea on exertion, syncope, or signs of right ventricular dysfunction. Patients with right ventricular failure are often volume overloaded, and careful volume management is imperative, especially in the setting of hypotension. Vasopressors and inotropes, rather than fluid boluses, are often required in shock to augment cardiac output and reduce the risk of exacerbating right ventricular ischemia. Intubation should be avoided if possible, although hypoxemia and hypercapnia may also worsen right-sided heart function. Emergency physicians should appreciate the role of pulmonary vasodilators in the treatment of pulmonary arterial hypertension and recognize that patients receiving these medications may rapidly develop right ventricular failure and even death without these therapies. Patients may require interventions not readily available in the ED, such as a pulmonary artery catheter, inhaled pulmonary vasodilators, and mechanical support with a right ventricular assist device or extracorporeal membrane oxygenation. Therefore, early consultation with a pulmonary hypertension specialist and transfer to a tertiary care center with invasive monitoring and mechanical support capabilities is advised.
引用
收藏
页码:619 / 628
页数:10
相关论文
共 50 条
  • [31] Prognostic value of pulmonary hypertension and right ventricular function in heart failure
    Sabri, F. Z.
    Abidi, G.
    Asadi, A.
    Arhlade, F.
    Habbal, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 392 - 392
  • [32] Right Ventricular Failure in Pulmonary Hypertension is Associated with Abnormal Mitochondrial Biogenesis
    Gomez-Arroyo, Jose G.
    Voelkel, Norbert F.
    Farkas, Laszlo
    Kraskauskas, Donatas
    Natarajan, Ramesh
    Abbate, Antonio
    Bigbee, John W.
    Lesnefsky, Edward J.
    Van Tassell, Benjamin
    Bogaard, Herman J.
    CIRCULATION, 2011, 124 (21)
  • [33] Pulmonary Arterial Hypertension With Right Ventricular Failure The Left Forgotten Ventricle
    Freed, Benjamin H.
    Gomberg-Maitland, Mardi
    CHEST, 2013, 144 (05) : 1435 - 1436
  • [34] Management of pulmonary hypertension and right ventricular failure: Another step forward
    Vlahakes, GJ
    ANNALS OF THORACIC SURGERY, 1996, 61 (04): : 1051 - 1052
  • [35] Characterization of right ventricular remodeling and failure in a chronic pulmonary hypertension model
    Aguero, Jaume
    Ishikawa, Kiyotake
    Hadri, Lahouaria
    Santos-Gallego, Carlos
    Fish, Kenneth
    Hammoudi, Nadjib
    Chaanine, Antoine
    Torquato, Samantha
    Naim, Charbel
    Ibanez, Borja
    Pereda, Daniel
    Garcia-Alvarez, Ana
    Fuster, Valentin
    Sengupta, Partho P.
    Leopold, Jane A.
    Hajjar, Roger J.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2014, 307 (08): : H1204 - H1215
  • [36] The Sequential Study of Metabolic Remodeling of Right Ventricular Failure in Pulmonary Hypertension
    Dai, Z. K.
    Wu, Y. H.
    Liu, I. C.
    Lo, S. H.
    Chen, I. C.
    Hsu, J. H.
    Wu, B. N.
    PEDIATRIC PULMONOLOGY, 2023, 58 : S128 - S129
  • [37] Treatment of right ventricular dysfunction and heart failure in pulmonary arterial hypertension
    Inampudi, Chakradhari
    Tedford, Ryan J.
    Hemnes, Anna R.
    Hansmann, Georg
    Bogaard, Harm-Jan
    Koestenberger, Martin
    Lang, Irene Marthe
    Brittain, Evan L.
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2020, 10 (05) : 1659 - 1674
  • [38] Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure
    Hester, James
    Ventetuolo, Corey
    Lahm, Tim
    COMPREHENSIVE PHYSIOLOGY, 2020, 10 (01) : 125 - 170
  • [39] Pulmonary Hypertension in Heart Failure Epidemiology, Right Ventricular Function, and Survival
    Gerges, Mario
    Gerges, Christian
    Pistritto, Anna-Maria
    Lang, Marie B.
    Trip, Pia
    Jakowitsch, Johannes
    Binder, Thomas
    Lang, Irene M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 192 (10) : 1234 - 1246
  • [40] Intensive care management of right ventricular failure and pulmonary hypertension crises
    Coleman, Ryan D.
    Chartan, Corey A.
    Mourani, Peter M.
    PEDIATRIC PULMONOLOGY, 2021, 56 (03) : 636 - 648